Episodic Migraine
📧 Sign up to get email alerts when something new happens for Episodic Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine [Phase 3]
Phase 3 pediatric study evaluating adverse events and changes in disease activity for oral atogepant in children aged 6-17 with episodic mig…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine [Phase 3]
Phase 3 trial evaluating onabotulinumtoxinA (BOTOX) injections for the prevention of episodic migraine in adults; the study was terminated a…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine [Phase 3]
A Phase 3 study evaluating oral atogepant for migraine prevention in Japanese participants with chronic or episodic migraine has completed a…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Occipital Blocks for Acute Migraine [Phase 3]
Results from a Phase 3 trial of occipital nerve blocks for acute migraine have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. [Phase 3]
Phase 3 trial update for atogepant in patients with episodic migraine who failed previous oral prophylactics; study completed with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients [Phase 4]
Phase 4 trial update on sustained benefit of AMG334 in adults with episodic migraine. Study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine [Phase 3]
Phase 3 trial update for galcanezumab in episodic migraine has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies [Phase 3]
Phase 3 trial evaluating AMG 334 Injection for preventing episodic migraines in adults after failure of other therapies has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Sphenopalatine Ganglion Blockade in Migraine [Phase 3]
Phase 3 clinical trial update on sphenopalatine ganglion blockade for episodic migraine.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine [Phase 2]
A Phase 2 multicenter trial evaluating LBR-101 for episodic migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine [Phase 3]
Phase 3 trial of atogepant for preventive treatment of episodic migraine has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients [Phase 3]
Phase 3 trial update for AMG 334 in adults with episodic migraine reports results; completed study with posted results.